Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of NovaMed, Inc. (“NovaMed” or the “Company”) (Nasdaq:NOVA) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired and taken private by Surgery Center Holdings, Inc. (“Surgery Partners”), an affiliate of H.I.G. Capital, LLC, in a transaction valued at approximately $214 million. Click here to learn how to join the action: http://www.rigrodskylong.com/news/NovaMedInc-NOVA.

Under the proposed agreement, Surgery Partners will acquire all of the outstanding common shares of NovaMed for $13.25 per share in cash. Furthermore, certain NovaMed directors and officers that in the aggregate own approximately 10.5% of NovaMed’s outstanding shares have entered into agreements with Surgery Partners to vote in favor of the merger.

The investigation concerns whether NovaMed’s board of directors failed to adequately shop the Company and obtain the best price possible for NovaMed’s shareholders before entering into the agreement with Surgery Partners. Indeed, according to Yahoo! Finance, at least one analyst has set an $18.00 per share price target for NovaMed stock.

If you own the common stock of NovaMed and purchased your shares before January 21, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Novamed (NASDAQ:NOVA)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Novamed Charts.
Novamed (NASDAQ:NOVA)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Novamed Charts.